Citation: Shuai Liu, Long Li, Lingbing Tan, Xiaozhen Liang. Inhibition of Herpes Simplex Virus-1 Replication by Natural Compound Honokiol .VIROLOGICA SINICA, 2019, 34(3) : 315-323.  http://dx.doi.org/10.1007/s12250-019-00104-5

Inhibition of Herpes Simplex Virus-1 Replication by Natural Compound Honokiol

cstr: 32224.14.s12250-019-00104-5
  • Corresponding author: Xiaozhen Liang, xzliang@ips.ac.cn
  • Received Date: 29 November 2018
    Accepted Date: 05 March 2019
    Published Date: 26 March 2019
    Available online: 01 June 2019
  • Honokiol is a pleiotropic natural compound isolated from Magnolia and has multiple biological and clinically relevant effects, including anticancer and antimicrobial function. However, the antiviral activity of honokiol has not yet been well studied. Here we showed that honokiol had no effect on herpes simplex virus-1 (HSV-1) entry, but inhibited HSV-1 viral DNA replication, gene expression and the production of new progeny viruses. The combination of honokiol and clinical drug acyclovir augmented inhibition of HSV-1 infection. Our results illustrate that honokiol could be a potential new candidate for clinical consideration in the treatment of HSV-1 infection alone or combination with other therapeutics.

  • 加载中
    1. Amblard F, Delinsky D, Arbiser JL, Schinazi RF (2006) Facile purification of honokiol and its antiviral and cytotoxic properties. J Med Chem 49:3426–3427
        doi: 10.1021/jm060268m

    2. Andrei G, Topalis D, Fiten P, McGuigan C, Balzarini J, Opdenakker G, Snoeck R (2012) In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs. J Virol 86:2641–2652
        doi: 10.1128/JVI.06620-11

    3. Averett C, Bhardwaj A, Arora S, Srivastava SK, Khan MA, Ahmad A, Singh S, Carter JE, Khushman M, Singh AP (2016) Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talk. Carcinogenesis 37:1052–1061
        doi: 10.1093/carcin/bgw096

    4. Bai X, Cerimele F, Ushio-Fukai M, Waqas M, Campbell PM, Govindarajan B, Der CJ, Battle T, Frank DA, Ye K, Murad E, Dubiel W, Soff G, Arbiser JL (2003) Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem 278:35501–35507
        doi: 10.1074/jbc.M302967200

    5. Balfour HH Jr, Benson C, Braun J, Cassens B, Erice A, Friedman-Kien A, Klein T, Polsky B, Safrin S (1994) Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. J Acquir Immune Defic Syndr 7:254–260

    6. Bang KH, Kim YK, Min BS, Na MK, Rhee YH, Lee JP, Bae KH (2000) Antifungal activity of magnolol and honokiol. Arch Pharm Res 23:46–49
        doi: 10.1007/BF02976465

    7. Darling AJ, Boose JA, Spaltro J (1998) Virus assay methods: accuracy and validation. Biologicals 26:105–110
        doi: 10.1006/biol.1998.0134

    8. Elion GB (1993) Acyclovir: discovery, mechanism of action, and selectivity. J Med Virol Suppl 1:2–6

    9. Elion GB, Furman PA, Fyfe JA, de Miranda P, Beauchamp L, Schaeffer HJ (1977) Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A 74:5716–5720
        doi: 10.1073/pnas.74.12.5716

    10. Fang CY, Chen SJ, Wu HN, Ping YH, Lin CY, Shiuan D, Chen CL, Lee YR, Huang KJ (2015) Honokiol, a lignan biphenol derived from the magnolia tree, inhibits dengue virus type 2 infection. Viruses 7:4894–4910
        doi: 10.3390/v7092852

    11. Field HJ, Vere Hodge RA (2013) Recent developments in antiherpesvirus drugs. Br Med Bull 106:213–249
        doi: 10.1093/bmb/ldt011

    12. Fried LE, Arbiser JL (2009) Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxid Redox Signal 11:1139–1148
        doi: 10.1089/ars.2009.2440

    13. Hafidh RR, Abdulamir AS, Abu Bakar F, Sekawi Z, Jahansheri F, Jalilian FA (2015) Novel antiviral activity of mung bean sprouts against respiratory syncytial virus and herpes simplex virus -1: an in vitro study on virally infected Vero and MRC-5 cell lines. BMC Complement Altern Med 15:179
        doi: 10.1186/s12906-015-0688-2

    14. Jacobo-Salcedo Mdel R, Gonzalez-Espindola LA, Alonso-Castro AJ, Gonzalez-Martinez Mdel R, Dominguez F, Garcia-Carranca A (2011) Antimicrobial activity and cytotoxic effects of Magnolia dealbata and its active compounds. Nat Prod Commun 6:1121–1124

    15. Jin J, Guo N, Zhang J, Ding Y, Tang X, Liang J, Li L, Deng X, Yu L (2010) The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans. Lett Appl Microbiol 51:351–357
        doi: 10.1111/lam.2010.51.issue-3

    16. Kumar A, Kumar Singh U, Chaudhary A (2013) Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities. Future Med Chem 5:809–829
        doi: 10.4155/fmc.13.32

    17. Kuribara H, Stavinoha WB, Maruyama Y (1999) Honokiol, a putative anxiolytic agent extracted from magnolia bark, has no diazepam-like side-effects in mice. J Pharm Pharmacol 51:97–103

    18. Kuribara H, Kishi E, Hattori N, Okada M, Maruyama Y (2000) The anxiolytic effect of two oriental herbal drugs in Japan attributed to honokiol from magnolia bark. J Pharm Pharmacol 52:1425–1429
        doi: 10.1111/(ISSN)2042-7158

    19. Lan KH, Wang YW, Lee WP, Lan KL, Tseng SH, Hung LR, Yen SH, Lin HC, Lee SD (2012) Multiple effects of Honokiol on the life cycle of hepatitis C virus. Liver Int 32:989–997
        doi: 10.1111/liv.2012.32.issue-6

    20. Leary JJ, Wittrock R, Sarisky RT, Weinberg A, Levin MJ (2002) Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines. Antimicrob Agents Chemother 46:762–768
        doi: 10.1128/AAC.46.3.762-768.2002

    21. Li Y, Wang S, Zhu H, Zheng C (2011) Cloning of the herpes simplex virus type 1 genome as a novel luciferase-tagged infectious bacterial artificial chromosome. Arch Virol 156:2267–2272
        doi: 10.1007/s00705-011-1094-9

    22. Li WL, Zhao XC, Zhao ZW, Huang YJ, Zhu XZ, Meng RZ, Shi C, Yu L, Guo N (2016) In vitro antimicrobial activity of honokiol against Staphylococcus aureus in biofilm mode. J Asian Nat Prod Res 18:1178–1185
        doi: 10.1080/10286020.2016.1194829

    23. Liou KT, Shen YC, Chen CF, Tsao CM, Tsai SK (2003) The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production. Eur J Pharmacol 475:19–27
        doi: 10.1016/S0014-2999(03)02121-6

    24. Maruyama Y, Kuribara H, Morita M, Yuzurihara M, Weintraub ST (1998) Identification of magnolol and honokiol as anxiolytic agents in extracts of saiboku-to, an oriental herbal medicine. J Nat Prod 61:135–138
        doi: 10.1021/np9702446

    25. Pan J, Zhang Q, Liu Q, Komas SM, Kalyanaraman B, Lubet RA, Wang Y, You M (2014) Honokiol inhibits lung tumorigenesis through inhibition of mitochondrial function. Cancer Prev Res (Phila) 7:1149–1159
        doi: 10.1158/1940-6207.CAPR-14-0091

    26. Park J, Lee J, Jung E, Park Y, Kim K, Park B, Jung K, Park E, Kim J, Park D (2004) In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp. Eur J Pharmacol 496:189–195
        doi: 10.1016/j.ejphar.2004.05.047

    27. Reusser P (1996) Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options. J Hosp Infect 33:235–248

    28. Sakaue Y, Domon H, Oda M, Takenaka S, Kubo M, Fukuyama Y, Okiji T, Terao Y (2016) Anti-biofilm and bactericidal effects of magnolia bark-derived magnolol and honokiol on Streptococcus mutans. Microbiol Immunol 60:10–16
        doi: 10.1111/1348-0421.12343

    29. Sato Y, Kato A, Maruzuru Y, Oyama M, Kozuka-Hata H, Arii J, Kawaguchi Y (2016) Cellular transcriptional coactivator RanBP10 and herpes simplex virus 1 ICP0 interact and synergistically promote viral gene expression and replication. J Virol 90:3173–3186
        doi: 10.1128/JVI.03043-15

    30. Shigemura K, Arbiser JL, Sun SY, Zayzafoon M, Johnstone PA, Fujisawa M, Gotoh A, Weksler B, Zhau HE, Chung LW (2007) Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer 109:1279–1289
        doi: 10.1002/(ISSN)1097-0142

    31. Song JM, Anandharaj A, Upadhyaya P, Kirtane AR, Kim JH, Hong KH, Panyam J, Kassie F (2016) Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors. Oncotarget 7:57752–57769

    32. Tan EL, Ooi EE, Lin CY, Tan HC, Ling AE, Lim B, Stanton LW (2004) Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs. Emerg Infect Dis 10:581–586
        doi: 10.3201/eid1004.030458

    33. Tan L, Zhang C, Dematos J, Kuang L, Jung JU, Liang X (2016) CD95 signaling inhibits B cell receptor-mediated gammaherpesviral replication in apoptosis-resistant B lymphoma cells. J Virol 90:9782–9796
        doi: 10.1128/JVI.00668-16

    34. Tian W, Xu D, Deng YC (2012) Honokiol, a multifunctional tumor cell death inducer. Pharmazie 67:811–816

    35. Wolf I, O'Kelly J, Wakimoto N, Nguyen A, Amblard F, Karlan BY, Arbiser JL, Koeffler HP (2007) Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest. Int J Oncol 30:1529–1537

    36. Woodbury A, Yu SP, Wei L, Garcia P (2013) Neuro-modulating effects of honokiol: a review. Front Neurol 4:130

    37. Wutzler P (1997) Antiviral therapy of herpes simplex and varicella-zoster virus infections. Intervirology 40:343–356
        doi: 10.1159/000150567

    38. Xu HL, Tang W, Du GH, Kokudo N (2011) Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of Magnolia officinalis. Drug Discov Ther 5:202–210
        doi: 10.5582/ddt.2011.v5.5.202

    39. Zhang Q, Zhao W, Ye C, Zhuang J, Chang C, Li Y, Huang X, Shen L, Li Y, Cui Y, Song J, Shen B, Eliaz I, Huang R, Ying H, Guo H, Yan J (2015) Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis. Oncotarget 6:37335–37348

  • 加载中

Figures(6)

Article Metrics

Article views(9415) PDF downloads(47) Cited by()

Related
Proportional views

    Inhibition of Herpes Simplex Virus-1 Replication by Natural Compound Honokiol

      Corresponding author: Xiaozhen Liang, xzliang@ips.ac.cn
    • 1. University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100039, China
    • 2. Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Shanghai 200031, China

    Abstract: Honokiol is a pleiotropic natural compound isolated from Magnolia and has multiple biological and clinically relevant effects, including anticancer and antimicrobial function. However, the antiviral activity of honokiol has not yet been well studied. Here we showed that honokiol had no effect on herpes simplex virus-1 (HSV-1) entry, but inhibited HSV-1 viral DNA replication, gene expression and the production of new progeny viruses. The combination of honokiol and clinical drug acyclovir augmented inhibition of HSV-1 infection. Our results illustrate that honokiol could be a potential new candidate for clinical consideration in the treatment of HSV-1 infection alone or combination with other therapeutics.